Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

被引：0
|
作者：
Juliusson, Gunnar [1 ,2 ]
Lazarevic, Vladimir [3 ]
Lehmann, Soren [4 ]
Derolf, Asa Rangert [5 ]
Mollgard, Lars [6 ]
Garelius, Hege [6 ]
Wennstrom, Lovisa [6 ]
Uggla, Bertil [7 ]
Antunovic, Petar [8 ]
Myhr-Eriksson, Kristina [9 ]
Wahlin, Anders [10 ]
Hoglund, Martin [11 ]
机构：
[1] Lund Univ, Stem Cell Ctr, Lund, Sweden
[2] Skane Univ Hosp, Dept Hematol & Coagula, Lund, Sweden
[3] Lund Univ, Skane Univ Hosp, Lund, Sweden
[4] Karolinska Inst, Stockholm, Sweden
[5] Karolinska Univ Hosp, Stockholm, Sweden
[6] Sahlgrens Univ Hosp, Gothenburg, Sweden
[7] Univ Hosp Orebro, Orebro, Sweden
[8] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[9] Sunderby Hosp, Lulea, Sweden
[10] Norrland Univ Hosp, Umea, Sweden
[11] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score.
    Falantes, Jose F.
    Martinez Robles, Violeta
    Bargay, Joan
    Deben, Guillermo
    Garrido, Ana
    Casano, Javier
    Salamero, Olga
    Bergua, Juan M.
    Colado, Enrique
    Garcia, Regina
    Pedro, Carmen
    Redondo, Santiago
    Tormo, Mar
    Bonanad, Santiago
    Diez-Campelo, Maria
    Perez-Encinas, Manuel
    de la Fuente, Adolfo
    Xicoy, Blanca
    Montesinos, Pau
    Ramos, Fernando
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] UPDATED RESULTS FROM A PHASE 2 STUDY OF PRACINOSTAT (P) IN COMBINATION WITH AZACITIDINE (AZA) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Garcia-Manero, G.
    Atallah, E.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Esquibel, V.
    Wood, K.
    Medeiros, B.
    HAEMATOLOGICA, 2015, 100 : 216 - 216
  • [33] Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort
    Ghosh, Shouriyo
    Kuchenbauer, Florian
    Stubbins, Ryan J.
    Chung, Shanee
    Narayanan, Sujaatha
    Nevill, Thomas J.
    Song, Kevin
    Rodrigo, Judith Anula
    White, Jennifer
    Roy, Claudie
    Abou Mourad, Yasser
    Nantel, Stephen H.
    Forrest, Donna L.
    Toze, Cynthia L.
    Hay, Kevin A.
    Power, Maryse
    Sanford, David
    BLOOD, 2023, 142
  • [34] INCREASED ABILITY TO TRANSPLANT AND IMPROVED SURVIVAL IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKEMIA (AML) AFTER INDUCTION WITH HIGH DOSE CYTARABINE AND MITOXANTRONE (HIDAC/MITO)
    Ramanathan, M.
    Cerny, Y.
    Raffel, G.
    Petrillo-Deluca, L.
    Tarrasky, N.
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S291 - S292
  • [35] Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015
    Chien, Li-Nien
    Tzeng, Huey-En
    Liu, Hung-Yi
    Chou, Wen-Chien
    Tien, Hwei-Fang
    Hou, Hsin-An
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (06) : 505 - 513
  • [36] Excessive cardiotoxicity despite excellent leukemia-free survival for pediatric patients with down syndrome (DS) and acute myeloid leukemia (AML): Results from POG (Pediatric Oncology Group) protocol 9421.
    O'Brien, Maureen
    Taub, Jeffrey
    Stine, Kimo
    Chang, Myron
    Ravindranath, Yaddanapudi
    Becton, David
    Van Houten Dahl, Gary
    BLOOD, 2006, 108 (11) : 168A - 169A
  • [37] Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups
    Amadori, Sergio
    Suciu, Stefan
    Selleslag, Dominik
    Rossetti, Elena
    Gaidano, Gianluca
    Musso, Maurizio
    Annino, Luciana
    Venditti, Adriano
    Magro, Domenico
    de Fabritiis, Paolo
    Muus, Petra
    Alimena, Giuliana
    Mancini, Marco
    Hagemeijer, Anne
    Cotugno, Francesca
    Vignetti, Marco
    Fazi, Paola
    Meert, Liv
    Ramadan, Safaa M.
    Willemze, Roelof
    de Witte, Theo
    Baron, Frederic
    BLOOD, 2014, 124 (21)
  • [38] Long-term survival of patients with acute myeloid leukemia - Updated results from two trials evaluating postinduction chemotherapy
    Bloomfield, CD
    Herzig, GP
    Peterson, BA
    Wolff, SN
    CANCER, 1997, 80 (11) : 2186 - 2190
  • [39] Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
    Onate, Guadalupe
    Pratcorona, Marta
    Garrido, Ana
    Artigas-Baleri, Alicia
    Bataller, Alex
    Tormo, Mar
    Arnan, Montserrat
    Vives, Susana
    Coll, Rosa
    Salamero, Olga
    Vall-Llovera, Ferran
    Sampol, Antonia
    Garcia, Antoni
    Cervera, Marta
    Avila, Sara Garcia
    Bargay, Joan
    Ortin, Xavier F.
    Nomdedeu, Josep
    Esteve, Jordi
    Sierra, Jorge
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [40] Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
    Guadalupe Oñate
    Marta Pratcorona
    Ana Garrido
    Alicia Artigas-Baleri
    Alex Bataller
    Mar Tormo
    Montserrat Arnan
    Susana Vives
    Rosa Coll
    Olga Salamero
    Ferran Vall-Llovera
    Antònia Sampol
    Antoni Garcia
    Marta Cervera
    Sara Garcia Avila
    Joan Bargay
    Xavier Ortín
    Josep F. Nomdedéu
    Jordi Esteve
    Jorge Sierra
    Blood Cancer Journal, 13
12345